Seranova Bio is an early-stage company dedicated to the creation of groundbreaking therapeutics. Our proprietary REAP (rapid extracellular antigen profiling) technology and analytics platform enable the discovery of the functional immune interactions that drive health and disease. We were founded in 2020 by Fred Hutchinson Cancer Center professor and serial academic entrepreneur Aaron Ring. Located in the vibrant biotech hub of South San Francisco, we are proudly supported by leading investors Foresite Capital Management and The Column Group.
| Website | http://www.seranovabio.com |
| Employees | 13 (10 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Therapeutics, Extracellular Vesicles, Biotechnology, Biomarkers, Immunology, Immune Response, Drug Discovery, Molecular Diagnostics, Biopharma, Rapid Diagnostics, Therapeutic Development, Pharmaceutical, Platform Technology, Biotechnology Research, Precision Medicine, Early Stage, Clinical Research, Life Sciences |
| Competitors | Zymergen, Inc., Zymeworks Inc., Amgen, Integrated DNA Technologies, Synthego Corporation, Sangamo Therapeutics, Inc., Regeneron, Caribou Biosciences, Editas Medicine, CRISPR Therapeutics +52 more (view full list) |
Looking for a particular Seranova Bio employee's phone or email?
Brent McKenzie is the Chief Scientific Officer of Seranova Bio.
10 people are employed at Seranova Bio.
Seranova Bio is based in South San Francisco, California.